Increasing use of ‘party drugs’ in people living with HIV on antiretrovirals
- 24 August 2015
- journal article
- review article
- Published by Wolters Kluwer Health in AIDS
- Vol. 29 (13) , 1585-1592
Abstract
Use of ‘party drugs’, a particular set of recreational drugs used in the context of ‘ChemSex’, is frequent among MSM living with HIV. A recently published observational study showed that more than half of HIV-infected MSM interviewed reported use of illicit substances in the previous 3 months, with frequent concomitant use of three or more drugs. These substances are a combination of ‘club drugs’ (methylenedioxymethamphetamine, gamma-hydroxybutyrate, ketamine, benzodiazepine) and drugs that are more specifically used in a sexualized context (methamphetamine, mephedrone, poppers and erectile dysfunction agents). Although formal data on pharmacokinetic or pharmacodynamic interactions between recreational drugs and antiretroviral agents are lacking, information regarding potentially toxic interactions can be theorized or sometimes conclusions may be drawn from case studies and cohort observational studies. However, the risk of coadministering party drugs and antiretrovirals should not be overestimated. The major risk for a drug–drug interaction is when using ritonavir-boosting or cobicistat-boosting agents, and maybe some nonnucleoside reverse transcriptase inhibitors. Knowledge of the metabolic pathways of ‘party drugs’ may help in advising patients on which illicit substances have a high potential for drug–drug interactions, as this is not the case for all.Keywords
This publication has 74 references indexed in Scilit:
- Dilated common bile duct and deranged liver function tests associated with ketamine use in two HIV-positive MSMInternational Journal of STD & AIDS, 2013
- Pharmacogenetics of cytochrome P450 2B6 (CYP2B6): advances on polymorphisms, mechanisms, and clinical relevanceFrontiers in Genetics, 2013
- A Systematic Review of Behavioral and Treatment Outcome Studies Among HIV-Infected Men Who Have Sex with Men Who Abuse Crystal MethamphetamineAIDS Patient Care and STDs, 2012
- Effect of Rifampicin on S-ketamine and S-norketamine Plasma Concentrations in Healthy Volunteers after Intravenous S-ketamine AdministrationAnesthesiology, 2011
- Efflux transporters- and cytochrome P-450-mediated interactions between drugs of abuse and antiretroviralsLife Sciences, 2011
- Specific Sex Drug Combinations Contribute to the Majority of Recent HIV Seroconversions Among MSM in the MACSJAIDS Journal of Acquired Immune Deficiency Syndromes, 2009
- Polydrug Use Among Club-Going Young Adults Recruited Through Time-Space SamplingSubstance Use & Misuse, 2009
- Associations between Crystal Methamphetamine Use and Potentially Unsafe Sexual Activity among Gay Men in AustraliaArchives of Sexual Behavior, 2007
- Contribution of CYP3A4, CYP2B6, and CYP2C9 Isoforms to N-Demethylation of Ketamine in Human Liver MicrosomesDrug Metabolism and Disposition, 2002
- Effects of enzyme induction, renal and cardiac function on ketamine plasma kinetics in patients with ketamine long-term analgosedationEuropean Journal of Drug Metabolism and Pharmacokinetics, 1990